CClinicalTrials.gg
RecruitingNCT05482906MS-CSIUpdated Mar 13, 2026

Common and Specific Information From Neuroimaging and Smartphone

An observational study in Multiple Sclerosis, sponsored by Nantes University Hospital. Recruiting at 1 site in France. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2026-03-13.

Sponsored by Nantes University Hospital · Observational

From the registry’s dates

  • Primary completion was expected by Apr 2026, 5 months ago, but the record still lists the study as recruiting.
  • Started Apr 2023; still recruiting 3 years 6 months later.
Study type
Observational
Model
Other
Time perspective
Prospective
Enrollment
100
Ages
18 Years and older
Sex
All
01

Study summary

Gait alteration is frequent in MS and limitation in walking ability is a major concern in MS patients. Umanit and LMJL (Nantes university) has developed a device call egait to assess walking ability in individuals (eg MS patients).

Read the detailed description

This device consists in a commercialized IMU sensor (MetaMotionR Sensor, Mbientilab) worn at the right hip, a smartphone app and dedicated algorithm/mathematical model to extract raw sensor data and calculate individual gait pattern (IGP). This IGP consists of a curve, based on quaternion and representing the rotation recorded by the IMU during an average gait cycle. Pursue previous works conducted on (IGP to assess) gait alteration in MS by adding (to IGP) new information from MRI.

02

Conditions studied

  • Multiple Sclerosis

Browse trials for

Keywords

  • Wearable sensor
  • Gait
  • MRI
03

In context

Multiple Sclerosis

3,460 studies on the registry are indexed under Multiple Sclerosis; 661 are open to participants now.

This study's planned enrollment of 100 is close to the median of 100 across 1,016 observational studies indexed under Multiple Sclerosis.

Browse Multiple Sclerosis studies →

Lead sponsor

Nantes University Hospital is the lead sponsor of 825 studies on the registry; 195 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years and older
Sexes eligible
All
Sampling method
Non-probability sample

Study population

MS patients cohort followed at Nantes university hospital or Rennes university hospital (OFSEP HD cohort)

Inclusion criteria

  • Diagnosis of MS based on McDonald criteria (including Relapsing-remitting and progressive MS)
  • Over 18 years old /age greater than 18 years
  • Patients followed at Nantes university hospital or Rennes university hospital
  • Last known EDSS before inclusion ranging from 0 to 6 inclusive/EDSS of 0 to 6 inclusive, prior inclusion
  • No relapse within 3 months
  • With a Medullar MRI planed as part as usual care
  • MRI scan can be performed within a maximum of 4 months after or before the walking test.
  • Affiliated person or beneficiary of a social security scheme

Exclusion criteria

Exclusion Criteria :

  • Bilateral aid needed to walk
  • Women who are pregnant
  • Patient having expressed their opposition
  • Patient under guardianship or security measure
05

Study design

Observational model
Other
Time perspective
Prospective
Enrollment
100 participants (estimated)
Patient registry
No

Interventions

  • OthereGait

    IMU sensor (as part of eGait device) worn at the hip during T25FW

    Also known as: Wearable sensor

06

What researchers measure

Primary outcomes

  1. Clustering analyze based on IGP

    IGP consists of a curve, based on quaternion and representing the rotation recorded by the IMU during an average gait cycle (0-1).

    Time frame: At the inclusion

  2. Clustering analyze based on EDSS score

    EDSS is an ordinal scale measuring disability and ranging from 0 (normal examination) to 10 (death due to MS) in a 0,5-point increments from score 1.

    Time frame: At the inclusion

  3. Clustering analyze based on MRI lesion load

    MRI characteristics are spinal and extraspinal lesion volumes.

    Time frame: At the inclusion

Secondary outcomes

  1. Correlation with disability

    Correlation of IGP obtained during a walk of 25 feet with Expanded Disability Status Scale (EDSS). EDSS is an ordinal scale measuring disability and ranging from 0 (normal examination) to 10 (death due to MS) in a 0,5-point increments from score 1. Here EDSS of 0 to 2 inclusive defined as mild, 2,5 to 4 inclusive as moderate and EFDSS of 4,5 to 6 inclusive defined as severe

    Time frame: At the inclusion

  2. Correlation with MRI lesion load

    Add lesion load (Spinal and extraspinal lesion volume) from MRI to previous correlation.

    Time frame: At the inclusion

  3. Building a predictive model for lesion load involving in walk ability from IGP

    Root mean square error between observed and lesion load predicted by the model, calculated by cross-validation.

    Time frame: At the inclusion

  4. Building a predictive model for group belonging from group established in main outcome based on IGP

    Multiclass accuracy between real and predict group, calculated by cross-validation

    Time frame: At the inclusion

07

Study locations

1 of 1 sites recruiting
  • Nantes University Hospital
    Nantes, Loire-Atlantique 44093, France
    Recruiting
08

References and documents

Individual participant data

Plan to share: No

No publications or documents are linked to this record.

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Mar 13, 2026, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT05482906
Lead sponsor
Nantes University Hospital
Collaborators
Rennes University Hospital
Responsible party
Sponsor
First posted
Aug 1, 2022
Start date
Apr 3, 2023
Primary completion
Apr 30, 2026 (estimated)
Completion
Jun 30, 2026 (estimated)
Last update
Mar 13, 2026

Study contacts

David LAPLAUD, PHD
Contact
david.laplaud@chu-nantes.fr
33 2 40 16 52 00

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

Contact study team

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion